Apolipoprotein C-III deficiency accelerates triglyceride hydrolysis by lipoprotein lipase in wild-type and apoE knockout mice

Journal of Lipid Research

Volumn 42, Issue 10, 2001, Pages 1578-1585

  Jong, Miek C ^a   Rensen, Patrick C N ^b   Dahlmans, Vivian E H ^a   Van Der Boom, Hans ^a   Van Berkel, Theo J C ^b   Havekes, Louis M ^a,c  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hypercholesterolemia; Transgenic mice; Triglyceride metabolism

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL ESTER; CHOLESTEROL OLEATE; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOLIPOPROTEIN C3 DEFICIENCY; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HYDROLYSIS; HYPERLIPIDEMIA; HYPOLIPEMIA; KNOCKOUT MOUSE; LIPID ABSORPTION; LIPOPROTEIN DEFICIENCY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHYLOMICRONS; CROSSES, GENETIC; FEMALE; GENE DELETION; HYDROLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TIME FACTORS; TRIGLYCERIDES;

EID: 0034749662     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Disorders of the lipoprotein and lipid metabolism
2. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia
3. Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients: Effects of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration
4. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very, low density and high density lipoproteins: Implications for the regulation of the catabolism of these lipoproteins
5. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and Al; Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo
6. Modulation of lipoprotein lipase activity by apolipoproteins: Effect of apolipoprotein C-III
7. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III
8. Effect of serum and C apolipoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase
9. The effect of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat
10. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII and E
11. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor
12. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice
13. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E
14. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice: Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particle
15. Chylolnicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice: Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E
16. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
17. Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient mice
18. Analysis of techniques to obtain plasma for measurements of levels of free fatty acids
19. Protein measurement with the Folin phenol reagent
20. A rapid method of total lipid extraction and purification
21. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo
22. The metabolism of very low density lipoproteins I. Preliminary in vitro and in vivo observations
23. Comparison between the use of isopropanol and tetramethylurea for the solubilisation and quantification of human serum very low density apolipoproteins
24. Delayed clearance of very low density and intermediate density lipoproteins with enhanced conversion to low density lipoprotein in WHHL rabbits
25. Impaired secretion of very low density lipoprotein-triglyceride by apolipoprotein E-deficient mouse hepatocytes
26. Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis
27. Selective liver targeting of antivirals by recombinant chylomicrons: A new therapeutic approach to hepatitis B
28. Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo
29. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl
30. Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice
31. Role of hepatic lipase in the Cla-1 mediated selective uptake of HDL cholesterol esters (Abstract)
32. In vivo evidence for selective uptake of cholesterol esters from apoB remnant lipoproteins in apoE-deficient mice (Abstract)
33. Further characterization of the metabolic properties of triglyceride-rich lipoproteins from human and mouse apoC-III transgenic mice
34. In the absence of the low density lipoprotein receptor, human apolipoprotein Cl overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
35. Hyperlipidemia and cutaneous abnormalities in transgenic mice over-expressing human apolipoprotein Cl
36. Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein Cl-deficient mice